Drawing for TEVIMBRA

USPTO serial 79314253

TEVIMBRA

Reviewed by CopyMark Law Group

Reg. 6848810Status 700Registered
Filing date
Status date
Registration date
Sep 20, 2022
Examiner
STEEL, ALYSSA PALADINO
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TEVIMBRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 7, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 2, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 13, 2022GPNXNOTIFICATION PROCESSED BY IB—
Oct 25, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 25, 2022FIMPFINAL DISPOSITION PROCESSED—
Oct 20, 2022GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Sep 20, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 20, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 24, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jul 5, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 5, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 29, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 15, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 31, 2022CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
May 2, 2022FINAFINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Mar 29, 2022ATRVATTORNEY REVIEW COMPLETED—
Mar 28, 2022ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Feb 22, 2022CRTPREG. CANCELLED - RESTORED TO PENDENCY—
Feb 22, 2022APETASSIGNED TO PETITION STAFF—
Feb 18, 2022RCIIREQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED—
Feb 3, 2022GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jan 31, 2022ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jan 4, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 14, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 19, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 19, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 29, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2021DOCKASSIGNED TO EXAMINER—
Jul 10, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 9, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 9, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 9, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 9, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 9, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 6, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 25, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance